Prothrombin complex concentrates: clinical use.
D000818:Animals; D001779:Blood Coagulation Factors / Q000009:adverse effects / Q000627:therapeutic use*; D005591:Chemical Fractionation; D002848:Chromatography, DEAE-Cellulose; D004285:Dogs; D005164:Factor IX / Q000494:pharmacology / Q000627:therapeutic use; D015949:Factor IXa; D005167:Factor VII / Q000627:therapeutic use; D005169:Factor VIII / Q000037:antagonists & inhibitors / Q000494:pharmacology; D005170:Factor X / Q000627:therapeutic use; D002836:Hemophilia B / Q000188:drug therapy; D006509:Hepatitis B / Q000209:etiology; D006526:Hepatitis C / Q000209:etiology; D006801:Humans; D010314:Partial Thromboplastin Time; D011516:Prothrombin / Q000627:therapeutic use; D013927:Thrombosis / Q000209:etiology; D014812:Vitamin K / Q000378:metabolism
D001779:Blood Coagulation Factors; D014812:Vitamin K; C025667:prothrombin complex concentrates; D005167:Factor VII; D011516:Prothrombin; D005169:Factor VIII; D005164:Factor IX; D005170:Factor X; D015949:Factor IXa